Amphion Innovations PLC Sale of partner company shares
August 30 2017 - 2:00AM
RNS Non-Regulatory
TIDMAMP
Amphion Innovations PLC
30 August 2017
Amphion Innovations plc
("Amphion" or "the Company")
30 August 2017
Sale of Partner Company Shares
London and New York, Amphion Innovations plc (AIM: AMP), the
developer of medical, life science, and technology businesses,
today announces that 1,700,000 shares in Partner Company, Motif Bio
have been sold in partial repayment of the loan facility (the
"Facility") originally announced on 5 June 2014. Following this
sale, Amphion holds 41,540,645 ordinary shares of Motif Bio,
representing 15.8% of the issued share capital.
Up to June 2017, Amphion has drawn down US $6.149 million under
the Facility, using certain assets of Amphion as collateral. This
capital has been used to support the development of the Partner
Companies which will in turn enhance the asset value of Amphion. If
not modified, the Facility will be due for final payment by
December 2017.
Discussions are continuing with the Lender in relation to a
rescheduling of the remaining amounts due. Our confidence in the
future of Motif Bio remains high and we will endeavor to minimise
the further reduction of the size of our holding.
For further information please contact:
Amphion Innovations Tel: +1 (212) 210 6224
Charlie Morgan
Panmure Gordon Limited (Nominated Tel: +44 (0)20
Adviser and Corporate Broker) 7886 2500
Freddy Crossley / Duncan Monteith
(Corporate Finance)
Charlie Leigh-Pemberton
(Corporate Broking)
Northland Capital Partners Tel: +44 (0)20
Limited (Joint Corporate Broker) 3861 6625
Patrick Claridge / David
Hignell (Corporate Finance)
John Howes (Corporate
Broking)
Walbrook PR Tel: +44 (0)20 7933
8780 or
Mike Wort/ Paul McManus amphion@walbrookpr.com
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses.
We use our extensive experience in company building to invest
and build shareholder value in high growth companies in the US and
UK. Amphion has significant shareholding in 7 Partner Companies
developing proven technologies targeting substantial commercial
marketplaces. The Amphion model has been refined to optimise the
commercialisation of patents and other intellectual property within
the Partner Companies. The Partner Companies collectively own or
control over 200 separately identified pieces of intellectual
property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEANPNALPXEFF
(END) Dow Jones Newswires
August 30, 2017 02:00 ET (06:00 GMT)
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024